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EditorialThe Value of ConnectionsIf you have looked at the cover of this issue, you may be
wondering why we chose a picture of an engineer repairing
telephone wires. The link to stem cells might not be immedi-
ately apparent. However, if you look closely, you will see
that there is an underlying theme. The telephone wires repre-
sent communication, and the drawing incorporates various
elements of the interconnected network of ethical and prac-
tical considerations involved in regenerative medicine, some
of which are highlighted in our issue (see if you can guess
the artist whose work we are subtly emulating!). The engineer
has a role to play too—as a depiction of the stem cell-based
approaches that are tapping into that network to help make
progress toward repair and regeneration.
The underlying prompt for the cover theme came from this
month’s review section, which looks at the importance of
communication at different stages of the research enterprise.
In their Forum, Erica Haimes and Ken Taylor advocate for strong
connections between researchers, clinicians, and patients to
help ensure smooth and effective provision of materials for
scientific research. Once materials are available, discussion
and exchange of reagents is more straightforward if information
about them is presented clearly. To that end, the two Letters
both comment and build upon a Forum that appeared in our
April issue calling for a standardized approach to nomenclature
for human pluripotent stem cell lines (Luong et al., 2011). The
Perspective from Christopher Goldring and colleagues arose
from communication, as it is based on discussions between
authors from a broad range of academic institutions and compa-
nies at a workshop. This article outlines the many different
factors that need to be taken into account for assessing the
safety of any stem cell-based therapy, regardless of the cell
type and source being used. Richard Maziarz and Dawn Driscoll
look at the other end of the process by outlining the need for
early interaction between those developing treatments and the
health care organizations that will ultimately be asked to pay
for them. Last but not least, we also focus on the importance
of communication with the general public, through patient advo-
cate Brooke Ellison, who gives us an overview of a new book,
‘‘Stem Cell Hope’’ by TIME Magazine reporter Alice Park; and
through outgoing ISSCR President Elaine Fuchs, who in her
President’s Note emphasizes the importance of active engage-
ment with lay audiences to promote understanding and appreci-
ation of stem cell research.
In the context of a journal, the concept of communication is
always relevant—it is our raison d’eˆtre. We are therefore happy
to be ‘‘communicating’’ a strong selection of new research find-
ings in this issue, ranging from regulation of lung stem cells to
suppression of aberrant transcripts in ESCs. Some papers
were available online ahead of the issue date; others are newly
available now. As always, you can find a summary of these
studies and how they relate to each other on our Editors’ Notes
page. Last month, we partnered with our sister journal Neuron to
bring you a focus on neural stem cells. This focus had two parts,
the first being a collection of review articles and primary researchpapers in our May issue. Then, later in the month, Neuron pub-
lished a special review feature covering a variety of different
topics related to neural stem cells and adult neurogenesis. This
month, Cell will also be publishing a collection of stem cell-
related review articles. As I discussed last year (Sweet, 2010),
Cell Stem Cell aims to follow the progress of the stem cell field
toward clinical translation, and the most recent addition to our
article type repertoire, ‘‘Clinical Progress,’’ fosters communica-
tion in that realm by presenting high-quality work that bridges
the divide between basic research and clinical application. In
this regard, we were pleased to see that last month Thomson
Reuters highlighted Cell Stem Cell as a Rising Star in the field
of Clinical Medicine, based on its citation record. Later this
year, we hope to promote interaction in a different way, by co-
hosting a Cell Symposium on Stem Cell Programming and Re-
programming in Lisbon, Portugal, from December 8th to 10th.
You can find information about the confirmed speakers and
how to register to attend online at http://bit.ly/i9UZBs. Alterna-
tively, if you prefer your missives about stem cell research in
a more succinct form, you may want join our growing band of
followers on Twitter (@CellStemCell).
As I write this Editorial, we are making preparations for the
ISSCR 2011 Annual Meeting. At the meeting itself, we are
delighted to be partnering with the University Health Network –
Toronto and the ISSCR to bring you a free half-day symposium
to honor the scientific legacy of Ernest McCulloch (see Iscove,
2011). All registered attendees for the ISSCR meeting are
welcome to join us for this Focus Session, which will take place
from 9:00 a.m. to 12:30 p.m. on Wednesday, June 15th. You can
find more information about it and register your interest on the
premeeting events page of the ISSCR website. Cell Press will
have an exhibition booth at the meeting (#811), and we invite
you to visit us to learn more about our various initiatives,
including the special issues mentioned above, to meet Scientific
Editors fromCell andCell StemCell, and to enter to win an iPad 2
by connecting with us on Facebook. At the booth, we will also
announce the results of our website-based ‘‘Best Paper’’
contest, so you can find out which of the six finalists was the
most popular among our voters. In addition, you will be able to
learn about an exciting new Cell Press tool designed to take
authors ‘‘behind the scenes’’ in the publication process. When
you pick up your delegate bag, you will see that it contains
a copy of this issue of Cell Stem Cell (perhaps that is even where
you found this Editorial). We are very grateful to Stemgent for
providing the sponsorship that made it possible for us to
distribute these journal copies. Stemgent focuses on developing
cutting-edge products for the stem cell community, including
a new mRNA-based reprogramming protocol based on a paper
that Cell Stem Cell published last year (Warren et al., 2010).
In closing, I’d like to offer congratulations in advance to Robert
Blelloch for receiving the ISSCR Outstanding Young Investigator
Award this year, and to the winners of two new awards: Kazu-
toshi Takahashi and Shinya Yamanaka, receiving the McEwen
Centre Award for Innovation, and Robert Klein, receiving theCell Stem Cell 8, June 3, 2011 ª2011 Elsevier Inc. 595
Cell Stem Cell
EditorialPublic Service Award. As always, I look forward to communi-
cating with as many of you as possible during the course of
the ISSCR meeting, and of course to hearing about all of the
latest and best research. See you there!
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